TRAF4 and inflammatory bowel disease: Based on the hypothesis that TRAF4 and TRAF6 may be activated prior to the clinical or endoscopic activation in patients with IBD, we sought to measure TRAF4 and TRAF6 expressions to explore their potential roles in IBD patients.